Immunity to asexual blood stage malaria and vaccine approaches.
about
Malaria endemicity and co-infection with tissue-dwelling parasites in Sub-Saharan Africa: a reviewProfiling the host response to malaria vaccination and malaria challengeImmunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsInduction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccineAcquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivaxImmune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections.Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum on LPS- or LPS+IFN-γ-stimulated J774A.1 cellsAntigen-specific B memory cell responses to Plasmodium falciparum malaria antigens and Schistosoma haematobium antigens in co-infected Malian childrenHuman immune responses that reduce the transmission of Plasmodium falciparum in African populations.Phenotypic profiling of CD8(+) T cells during Plasmodium vivax blood-stage infection.A flow cytometric assay to quantify invasion of red blood cells by rodent Plasmodium parasites in vivoNaturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen.Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individualsHigh-Level Expression of Immunogenic Recombinant Plasmodium vivax Merozoite Surface Protein (Pvmsp-142 kDa) in pGEX 6P1 Vector.Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax.The immunological challenge to developing a vaccine to the blood stages of malaria parasites.In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity.Plasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential.Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.A comparative study of natural immune responses against Plasmodium vivax C-terminal merozoite surface protein-1 (PvMSP-1) and apical membrane antigen-1 (PvAMA-1) in two endemic settingsHigh levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in MyanmarThe risk of malarial infections and disease in Papua New Guinean children.Mixed allele malaria vaccines: host protection and within-host selection.Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.Effect of GPI anchor moiety on the immunogenicity of DNA plasmids encoding the 19-kDa C-terminal portion of Plasmodium falciparum MSP-1.Co-infection restrains Litomosoides sigmodontis filarial load and plasmodial P. yoelii but not P. chabaudi parasitaemia in mice.Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure.Immune response to Plasmodium vivax has a potential to reduce malaria severity.Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure.Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.Immunophenotyping of blood mononuclear cells from P. berghei (NK-65) infected and immunized BALB/c mice.Host immune response is severely compromised during lethal Plasmodium vinckei infection.Antibodies to the Plasmodium falciparum rhoptry protein RAP-2/RSP-2 in relation to anaemia in Cameroonian children.Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL-6.
P2860
Q26786020-65DA451C-B3B4-4B98-95F7-4AE246296D22Q26800494-59792C45-50D0-4C2B-BB5B-2D76CC0474DCQ28742130-6FBE9FE1-D885-408D-B4C3-946F1006C356Q30783460-5517575E-AA53-48F3-BA4E-0B1F93E8A58AQ33214292-628C59B0-54E9-47E0-B168-DAE2F316C4E4Q33380204-996860B7-9B5E-42FB-A570-9B1292B338D3Q33530114-327B4353-D198-4388-BD43-E090A9D82CFAQ33533328-39D3AB94-AEFD-43BA-9703-2B92D1C788A8Q33746686-27DF3EF1-3345-46FE-8837-D8766228BC86Q33855899-B1DE66DE-144D-4DCC-B58A-D7C618B58677Q34291036-E3150856-654F-4064-9553-61CFBCB59A40Q34302523-7FF1174A-580D-48EA-B4A8-A03F322264CCQ34641186-6B4FB94F-948E-4C96-8683-7E82FB426948Q35085645-3A2E3317-4CB8-421A-9BA6-93A60436AD6DQ35120742-DB4D3429-A7DC-4B4B-B3A9-FFA0E812DC7FQ35494820-D11B1A47-D3F0-4591-8307-C64C792222DDQ35606249-C900A6FA-4879-47D5-A2A9-C094CBFEDB54Q35668254-77C7914E-ECAF-4B60-A6D9-97B6C2621FF7Q35833807-A0FA93FE-0FAC-4C9C-BCD6-0B6EE1544CBAQ35884247-789DB747-A523-4981-BDE3-B3D6F1A2022CQ35898819-4CD2D41F-C189-42E6-9917-D44D542A9075Q35926359-A3B8F0C5-63FE-4EA4-BAFD-DFE2ED7C2AFBQ36204459-0F611F62-5556-4104-A2C3-58C9F722D851Q36215933-DE285695-012A-4BB2-8EF3-12119F519890Q36227228-714C7732-7744-4E5C-BB2A-A1C6B457809EQ36367968-8257B177-D8DB-45B5-B6BC-933029F8399FQ36908779-72A9B815-5927-4F7B-9F15-71EB294C6161Q37088901-017F8B55-E085-468F-918F-739DC8C21A63Q37172956-C6F5E9A0-BAAE-4F91-8C98-7875A256B7C9Q37202344-6E65794F-F56F-49DC-9563-D61D5C67F0B1Q37239807-98CB8241-9998-4719-9A35-6917725E1D92Q37693547-E7EBC090-3248-4D44-9AD9-370D277CE4AAQ38938701-D5252CB3-41FB-4B00-9F84-FAA64E745F6CQ38946873-EF920FA8-3087-433A-AFBF-324E2F2BB398Q39062944-29CB9E0E-5B9D-44C1-BA10-504248BCC1B6Q39298376-87EB660D-01D3-48A1-9E25-83E2E8DE1E3EQ40289044-1A6195B9-BDD6-4A1C-A07E-5B53C714C0DDQ41159222-283CA4BF-FCD3-4281-B861-3FF05DBB9C90Q46162111-14F92F31-6021-4D8F-A2B0-B849E312D874Q47826070-601BD5F2-E299-46A5-AD75-9F7A68FFAD60
P2860
Immunity to asexual blood stage malaria and vaccine approaches.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunity to asexual blood stage malaria and vaccine approaches.
@ast
Immunity to asexual blood stage malaria and vaccine approaches.
@en
Immunity to asexual blood stage malaria and vaccine approaches.
@nl
type
label
Immunity to asexual blood stage malaria and vaccine approaches.
@ast
Immunity to asexual blood stage malaria and vaccine approaches.
@en
Immunity to asexual blood stage malaria and vaccine approaches.
@nl
prefLabel
Immunity to asexual blood stage malaria and vaccine approaches.
@ast
Immunity to asexual blood stage malaria and vaccine approaches.
@en
Immunity to asexual blood stage malaria and vaccine approaches.
@nl
P2093
P2860
P1476
Immunity to asexual blood stage malaria and vaccine approaches.
@en
P2093
Jiraprapa Wipasa
Salenna Elliott
P2860
P304
P356
10.1046/J.1440-1711.2002.01107.X
P577
2002-10-01T00:00:00Z